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Reactive oxygen species (ROS) play an important role in physiological processes, but - when being in excess - ROS cause oxidative 
damage to molecules. Under physiological conditions, the production and detoxification of ROS are more-or-less balanced. Also in the 
thyroid, ROS and free radicals participate in physiological and pathological processes in the gland. For example, hydrogen peroxide 
(H2O2) is crucial for thyroid hormone biosynthesis, acting at different steps of the process. Additionally, H2O2 is believed to participate 
in the Wolff-Chaikoff’s effect, undergoing in conditions of iodide excess in the thyroid. It is the purpose of this review to attempt a syn-
thesis of what we currently know of thyroid hormones production and their relation to oxidative stress and selenium, a trace element. 
Biomed Rev 2009; 20: 17–29.
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INTRODUCTION
Oxidative stress is a general term used to describe a state 
of damage caused by reactive oxygen species (ROS). This 
damage can affect a specific molecule or the entire organism. 
Reactive oxygen species, such as free radicals and peroxides, 
represent a class of molecules that are derived from the me-
tabolism of oxygen and exist in all aerobic organisms . Much 
of the reactive oxygen species production occurs in mito-
chondria, via oxidative phosphorylation. Because the mito-
chondria contain specific receptors for the thyroid hormones, 
being one of the “favorite” target for them, the concept about 
a possible relationship between reactive oxygen species pro-
duction and thyroid pathology has increasing importance. 
Here, we highlight oxidative stress and selenium involve-
ment in thyroid gland pathophysiology at experimental and 
clinical conditions. 
THYROID HORMONES SYNTHESIS: OXIDATIVE STRESS IN 
PHYSIOLOGICAL CONDITIONS
The thyroid contains two hormones, L-thyroxine (tetraio-
dothyronine, T4) and L-triiodothyronine (T3) (Fig. 1). Iodine 
is an indispensable component of the thyroid hormones, 
comprising 65% of T4’s weight, and 58% of T3’s. The thyroid 
hormones are the only iodine-containing compounds with 
established physiologic significance in vertebrates. Ingested 
iodine is absorbed through the small intestine and transported 
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in the plasma to the thyroid, where it is concentrated, oxi-
dized, and then incorporated into thyroglobulin (Tg) to form 
monoiodotyrosine (MIT) and diiodotyrosine (DIT) and later 
T4 and T3 (Figure 2). After a variable period of storage in thy-
roid follicles, Tg is subjected to proteolysis and the released 
hormones are secreted into the circulation, where specific 
binding proteins carry them to target tissues. 
Thyroperoxidase (TPO) 
After concentrating iodide, the thyroid rapidly oxidizes it and 
binds it to tyrosyl residues in Tg, followed by coupling of io-
dotyrosines to form T4 and T3. The process requires the pres-
ence of iodide, a peroxidase (TPO), a supply of H2O2, and an 
iodine acceptor protein (Tg). Thyroperoxidase oxidizes io-
dide in the presence of H2O2. The enzyme activity is depend-
ent on the association with a heme, the ferriprotoporphyrin 
IX or a closely related porphyrin (1,2). Chemical removal of 
the prosthetic group inactivates the enzyme, and recombina-
tion with the heme protein restores activity (3). The apopro-
tein from human thyroid is not always fully saturated with 
its prosthetic group (4). Some congenitally goitrous children 
have poor peroxidase function because the apoprotein has 
weak binding for the heme group (4).
H2O2 generating system
By definition, a peroxidase requires H2O2 for its oxida-
tive function. H2O2 is produced at the apical plasma mem-
brane by an enzyme that requires both calcium and NADPH 
(5,6,7). The enzyme named thyroid NADPH oxidase, prob-
ably composed of several molecular species, has not yet 
been completely characterized. Complementary DNAs cor-
responding to two members of the NADPH oxidase family 
of 1,551 (ThOX1) and 1,548 (ThOX2) amino acids have 
been cloned. The two proteins share 83% homology; in their 
N-terminal part, they present 43% similarity with TPO. The 
C-terminal part is clearly related to leukocyte gp91phox. Both 
ThOX proteins contain intracellular consensus sequence 
for FAD and NADPH binding sites and two EF-hand mo-
tives as calcium binding sites (8,9). The current model as-
signs seven transmembrane domains to ThOX1 and ThOX2. 
The two proteins are glycoproteins, their apparent molecular 
mass ranges from 170-180 kDa. Immunolabeling experi-
ments revealed the presence of ThOX inside the cells and 
at the apical plasma membrane (8,10). ThOX proteins are 
components of the H2O2 generating system, but additional 
polypeptide chains are required to get the complete thyroid 
H2O2 generating system (11). One scheme for H2O2 genera-
tion by NADPH oxidase proposes the reduction of O2 into 
superoxide ion (O2-) and the conversion to H2O2 by superox-
ide dismutase (12). Another scheme involves the direct for-
mation of H2O2 from O2 (13). TSH, via the cAMP cascade, 
activates the expression of ThOX1 and ThOX2 (14). TSH 
Figure 1. Structural formula of thyroid hormones and precursor compounds. From www.THYROIDMANAGER.ORG)
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Figure 2. The iodide cycle. Ingested iodide is trapped in the thyroid, oxidized, and bound to tyrosine to form iodotyrosines in 
thyroglobulin (TG); coupling of iodotyrosyl residues forms T4 and T3. Hormone secreted by the gland is transported in serum. 
Some T4 is deiodinated to T3. The hormone exerts its metabolic effect on the cell and is ultimately deiodinated; the iodide is 
reused or excreted in the kidney. A second cycle goes on inside the thyroid gland, with deiodination of iodotyrosines generating 
iodide, some of which is reused without leaving the thyroid. From www.THYROIDMANAGER.ORG
stimulates NADPH oxidase activity and H2O2 production. 
This effect has been reported to be mediated through cAMP 
in dog thyrocytes (15,16) but by the phospholipase C/calci-
um cascade in FRTL-5 cells (17) and porcine thyrocytes (16). 
H2O2 generation in in vitro systems appears to be regulated 
by iodide (18). At low concentrations and short-term incuba-
tion, iodide increases H2O2 production (19) whereas, at high 
iodide concentrations, H2O2 generation is inhibited (20). 
The H2O2 generating system and TPO are closely associ-
ated.The interaction between Duox and TPO was studied 
using incubated follicles prepared from patients undergo-
ing thyroidectomy, and COS-7 cells transiently transfected.: 
Duox and TPO from membranes are coprecipitated,  This 
association is up-regulated through the Gq-phospholipase C-
Ca(2+)-protein kinase C pathwa and down-regulated through 
the Gs-cAMP-protein kinase A pathway, H(2)O(2) increases 
the association of Duox1 and Duox2 to TPO in cells and in 
membranes. Coimmunoprecipitations show that Duox and 
TPO locate closely in the plasma membranes of human thy-
rocytes, and this association can be modulated by H(2)O(2), 
optimizing working efficiency and minimizing H(2)O(2) 
spillage (21) 
Thyroglobulin iodination and hormone synthesis
Thyroglobulin is the most abundant protein in the thyroid 
gland; its concentration within the follicular lumen can reach 
200-300 g/L. Its main function is to provide the polypeptide 
backbone for synthesis and storage of thyroid hormones (22). 
It also offers a convenient depot for iodine storage and re-
trieval when external iodine availability is scarce or uneven. 
Neosynthesised Tg polypeptide chains entering the lumen 
of the rough endoplasmic reticulum (RER) are subjected to 
core glycosylation, dimerises and are transferred to the Golgi 
where they undergo terminal glycosylation (Fig.3.). Iodina-
tion and hormone formation of Tg occur at the apical plasma 
membrane-lumen boundary and the mature hormone-con-
taining molecules are stored in the follicular lumen, where 
they make up the bulk of the thyroid follicle colloid content.
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Figure 3. A polarized thyroid epithelial cell synthesiz-
ing soluble proteins, Tg (▲) and lysosomal enzymes 
(X) and membrane proteins, NIS (┴) and TPO (°). The 
polypeptide chain(s) generated by RER membrane-
bound polysomes, enter the lumen of RER for the former 
and remain inserted into the RER membrane for the lat-
ter. Inside the lumen of RER, newly-synthesized proteins 
undergo core glycosylation and by interacting with 
chaperones acquire their conformation. Proteins are 
then transported to the Golgi apparatus (G), where ter-
minal glycosylation and other post-translational reac-
tions take place. In the Trans-Golgi network (TGN), ma-
ture proteins undergo sorting processes and are packed 
into transport vesicles. The vesicles carrying soluble 
proteins (inside the vesicle) and membrane proteins (as 
integral vesicle membrane protein) deliver them at the 
appropriate plasma membrane domain: the apical do-
main (1) and (2) or the basolateral domain (4). Vesicles 
carrying lysosomal enzymes (3) conveyed their content 
to prelysosomes or late endosomes (LE) and lysosomes 
(L). Apical plasma membrane proteins may reach their 
final destination by an alternative route involving a 
transient transfer to and then a retrieval and transport 
(*) from the basolateral membrane domain to the apical 
domain. From www.THYROIDMANAGER.ORG
Figure 4. Iodination of Tg at the apical plasma membrane-follicle lumen boundary From www.THYROIDMANAGER.ORG
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The step preliminary to thyroid hormone formation is the at-
tachment of iodine to tyrosyl residues in Tg to produce MIT 
and DIT. This process occurs at the apical plasma membrane-
follicle lumen boundary and involves H2O2, iodide, TPO, 
and glycosylated Tg. All rendezvous at the apical membrane 
to achieve Tg iodination. First, iodide must be oxidized to an 
iodinating form. An extensive literature has sought to iden-
tify the iodinating species, but the issue is still not resolved 
(23). One scheme proposes that oxidation produces free radi-
cals of iodine and tyrosine, while both are bound to TPO to 
form MIT which then separates from the enzyme . Further 
reaction between free radicals of iodine and MIT gives DIT. 
Experimental studies by Taurog (23) and others suggest that 
the TPO reduction occurs directly in a two electron reaction. 
A second proposal, based on studies of rapid spectral absorp-
tion changes (24), is that TPO-I+ is the iodination intermedi-
ate and that the preferred route is oxidation of TPO by H2O2 
followed by two electron oxidation of I- to I+, which then 
reacts within a tyrosine. As a third possibility, Taurog (23) 
proposed a reaction between oxidized TPO and I- to produce 
hypoiodite (OI-), which also involves a two electron reaction. 
Whatever the precise nature of the iodinating species, it is 
clear that iodide is oxidized by H2O2 and TPO, and trans-
ferred to the tyrosyl groups of Tg. All tyrosine residues of 
Tg are not equally accessible to iodination. The molecule has 
about 132 tyrosyl residues among its two identical chains; at 
most, only about 1/3 of the tyrosyls are iodinated. As isolated 
from the thyroid, Tg rarely contains more than 1% iodine or 
about 52 iodine atoms. The final step in hormone synthesis is 
the coupling of two consenting iodotyrosyl residues to form 
iodothyronine (Fig. 5). Two DIT form T4; one DIT and one 
MIT form T3. Coupling takes place while both acceptor and 
donor iodotyrosyl are in peptide linkage within the Tg mole-
cule.The reaction is catalyzed by TPO, required H2O2 (25, 26, 
27, 28) and is stringently dependent on Tg structure (29).The 
generation of the iodothyronine residue involves the forma-
tion of an ether bond between the iodophenol part of a donor 
tyrosyl and the hydroxyl group of the acceptor tyrosyl. After 
the cleavage reaction that gives the iodophenol, the alanine 
side chain of the donor tyrosyl remains in the Tg polypeptide 
chain as dehydroalanine (30, 31, 32). Observations both in 
vivo and in vitro show an appreciable delay in coupling after 
initial formation of iodotyrosines. A typical distribution for a 
Tg containing 0.5% iodine (a normal amount for iodine-suf-
ficient individuals) is 5 residues MIT, 5 of DIT, 2.5 of T4 and 
0.7 of T3 (22). More iodine increases the ratios of DIT/MIT 
and T4/T3, while iodine deficiency decreases them. In addi-
tion to its role as component of the iodoamino acids, iodine 
is associated with cleavage of peptide bonds of Tg, at least in 
vitro (22). This has been attributed to generation of free radi-
cals during oxidation (33). Exposure of Tg to reducing agents 
yields an N-terminal peptide of about 20-26kDa, depending 
Figure 5. Possible coupling reaction sequence. Oxidation of iodotyrosines may produce iodotyrosyl radicals. The free radicals 
could combine to generate the iodothyronine residue (at the tyrosine acceptor site) and a dehydroalanine residue (at the tyrosine 
donor site), which in the presence of H2O converts into a serine. From www.THYROIDMANAGER.ORG
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on the animal species, that contains the major hormonogenic 
site of Tg (34). This peptide appears in parallel with iodi-
nation or may slightly precede it (35). Further addition of 
iodine cleaves the 26kDa further, to produce an 18kDa (on 
human Tg), an event that also occurs with TSH stimulation 
(35). Thus, iodination-associated cleavage appears to be part 
of the maturation of the Tg molecule. The amount of iodine 
has important effects on thyroid hormone production (36). 
The initial reaction between TPO and H2O2 produces the 
so-called “compound I”, which oxidizes iodide and iodinates 
Tg. Next, the two reactants form compound II, which is nec-
essary for the coupling reaction to make thyroid hormones. 
However, if excessive iodine is present, conversion to com-
pound II does not take place, and hormone synthesis is im-
paired. Other iodinated compounds occasionally inhabit the 
thyroid. Thyroalbumin excited considerable interest several 
decades ago. This is an iodinated albumin, recently shown to 
be serum albumin that is iodinated in the thyroid (37). Occa-
sionally, large amounts are found in certain thyroid diseases, 
including Hashimoto’s thyroiditis (38), congenital metabolic 
defects (39), thyrotoxicosis (40) and thyroid carcinoma (41). 
In all these cases, there are abnormalities in thyroid structure 
which might explain the access of serum albumin to intrathy-
roidal iodination sites. However, in physiological conditions, 
serum albumin can reach thyroid follicle lumina by transcy-
tosis i.e. basolateral endocytosis and vesicular transport to 
the apical plasma membrane (42). The thyroid also iodinates 
lipids and many different iodolipids have been described af-
ter high doses of iodide in vitro (43. 44). Of particular in-
terest is 2-iodohexadecanal (45, 46). It occurs in the thyroid 
of several species following administration of KI, and its 
amount increases linearly with additional iodine, in contrast 
to iodination of Tg which eventually is inhibited by excess 
iodide. This compound inhibits the action of NADPH oxi-
dase, which is responsible for H2O2 production (47). These 
findings have led to the suggestion that iodination of lipids 
impairs H2O2 production and, therefore, decreases further 
Tg iodination. This is the most probable mechanism for the 
Wolff-Chaikoff effect (18).
THYROID HORMONES PARADOX
Thyroid hormones themselves also pose a paradox. This 
`thyroid hormone paradox’ is that they both promote damage 
by ROS, by stimulating aerobic metabolic activity, but they 
also act as antioxidants themselves, as well as influencing 
other antioxidant defences (48). Hyperthyroidism increases 
lipid peroxidation in young, old and very old rats and hy-
pothyroidism results in lower levels of lipid peroxidation 
in young rats (49). One study reports that hypothyroidism 
in rats significantly decreases lipid peroxidation in skeletal 
muscle but not thymus, spleen or lymph nodes (50), whilst 
another reports that it results in no reduction in lipid per-
oxidation in liver, cardiac or skeletal muscle (51). In rats, 
hyperthyroidism results in increased levels of lipid peroxida-
tion products in liver, heart, soleus muscle and lymph nodes 
(51, 52). Other experimental stuy on adult, white, Wistar rat 
reports a significant increase in lipid peroxidation and pro-
teins carbonyl in the main thyroid hormones target tissues: 
thyroid gland, heart, liver, skeletal muscle, brain (53, 54, 55, 
56). Higher levels of mitochondrial enzymes and increased 
ROS production by submitochondrial particles has also been 
reported for hyperthyroid rats (57,58). 
Thyroid-induced increases in lipid peroxidation are not 
restricted to enhanced mitochondrial activity. For example, 
in rats T3 increases superoxide production, NADPH oxidase 
activity and lipid peroxidation in hepatic microsomes (57). 
Polymorphonuclear leucocytes from hyperthyroid rats have 
an enhanced capacity to produce superoxide when stimulated 
in vitro and this seems primarily related to thyroid-hormone-
enhanced NADPH oxidase activity. A similar effect has been 
observed in phagocytes from hyperthyroid humans (58). 
Both T4 and T3 can also stimulate, in vitro, the activity of 
myeloperoxidase isolated from human leukocytes (59). 
Low-density lipoproteins isolated from hyperthyroid hu-
mans also show an elevated lipid peroxidation compared to 
those from euthyroid individuals, intriguingly as do those 
from hypothyroid individuals (60). These results suggest 
that, at least in humans, the euthyroid condition represents 
that which results in the minimal peroxidative damage to 
low-density lipoproteins. Whether this also applies to other 
molecules capable of oxidative damage is not known.
Antioxidant enzymes include superoxide dismutase 
(SOD), glutathione peroxidases and catalases (61). The in-
fluence of thyroid status on antioxidant defences is mixed 
and there appears to be no consistent pattern. Some studies 
report that hyperthyroidism increases vitamin E content of 
cardiac muscle (51,62) whilst others show no effect (52). 
Hyperthyroidism increases glutathione levels in erythrocytes 
and serum (63,64) but decreases glutathione levels in rat 
liver (63). During hyperthyroidism, glutathione peroxidase 
is elevated in liver, erythrocytes, spleen and skeletal mus-
cle (63,64) diminished in thymus, heart and skeletal muscle 
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(52,63,64) and unaffected in liver and heart (57). Whilst in 
hypothyroidism it has been reported as both increased in 
cardiac and skeletal muscle (57,62) and reduced in thymus 
and skeletal muscle (51,52). Glutathione reductase activity 
appears relatively unaffected by thyroid status (51) although 
it has been reported to be elevated in liver during hyperthy-
roidism (63). Catalase activity is reported both to increase in 
skeletal muscle (50) and decrease in thymus, spleen, cardiac 
and skeletal muscle (50,52,64) during hyperthyroidism. The 
activity of Cu2+,Zn2+ -, SOD is also reported to be increased 
in thymus, leucocytes and skeletal muscle (50) but decreased 
in cardiac and skeletal muscle (52) whilst Mn2+ - SOD is 
reported to be increased in leucocytes, thymus, spleen, car-
diac and skeletal muscle (50,52) during hyperthyroidism. No 
general pattern can be discerned from the diverse responses 
of antioxidant defences to hyperthyroidism. Most studies 
involving hypothyroidism report no significant influence on 
levels of either antioxidant scavengers or enzymes.
The question as to whether thyroid themselves can act as 
antioxidant compounds was first raised after De Caro (65) 
observed that T4 can decrease oxygen uptake by solutions 
of unsaturated fatty acids. It was later shown that T4 could 
also prevent lipid peroxidation in isolated erythrocytes and 
liver homogenates (66), and that T4, T3 and 3,5-T2 (but not 
the non-iodinated thyronine) could inhibit lipid peroxidation 
in isolated rat liver mitochondria as well as dramatically in-
hibiting carbon tetrachloride accelerated lipid peroxidation 
(67). As with many early studies, the T4 concentrations used 
in these experiments were high and non-physiological. Wynn 
(68) used an in vitro system to show that Fe2+ could activate 
lipid peroxidation of rat liver microsomes and that T4 could 
terminate such lipid peroxidation by acting as an antioxidant. 
The lowest T4 concentration examined was 100 nm, and at 
this concentration, T4, rT3 and T3 all showed antioxidant ac-
tivity (in decreasing intensity) and their antioxidant abilities 
were greater than that of either vitamin E or ascorbic acid in 
the same system. He also showed that pharmacological doses 
of T4 could reduce in vivo the peroxide content of epididy-
mal fat pads in the rat (68). Because of its relative metabolic 
inertness such a tissue is unlikely to have had significant 
thyroid-hormone-induced peroxidation.
 In these lipid peroxidation experiments, T4 was degrad-
ed when exerting its antioxidant effects. This was consist-
ent with the finding that the in vivo rate of T4 degradation 
seemed to be related to its clinical effect (69). Lipid peroxi-
dation can also be catalyzed in vitro by hemoglobin, and io-
dothyronines inhibit such peroxidation, and are more potent 
antioxidants in these situations than vitamin E, glutathione or 
ascorbic acid (70). The physiological importance of the anti-
oxidant properties of thyroid hormones was questioned when 
the antioxidant capacities of both T3 and T4 in retarding the 
auto-oxidation of rat brain homogenate and free-radical-me-
diated oxidation of rat erythrocyte membranes was evaluated 
and found to be very low (1±2%) at hormonal concentrations 
of 50 nm but substantial at micromolar hormonal levels ( 71).
 That thyroid hormones possibly have antioxidant activity 
is also illustrated by the finding that although resting neu-
trophils exhibit negligible deiodination of both T4 and T3, 
when they are stimulated to phagocytose (and ROS produc-
tion is consequently activated), the deiodination of both T4 
and T3 dramatically increases severalfold. Neutrophils from 
individuals with chronic granulomatous disease, which are 
deficient in the capacity to produce ROS, degrade T4 and 
T3 poorly during phagocytosis (72). Examination of the po-
tential role of thyroid hormones as potent natural membrane 
antioxidants also deserves attention in light of other observa-
tions. A strong correlation has been observed in rats between 
the phospholipid content of tissues and their T4 content. Anal-
ysis of this relationship, assuming that all T4 is associated 
with membranes, suggests a molar ratio of T4:phospholipid 
of approximately 1:1000. This is similar to the molar ratio of 
vitamin E: lipid observed in biological membranes which is 
of the order of 1:2000±3000 (73). Whilst obviously not all 
thyroid hormone molecules are associated with membranes, 
measurements in human erythrocytes suggest that approxi-
mately half of cellular thyroid hormone molecules (34% of 
T4 and 60% of T3) are associated with membranes (74). As 
the human erythrocytes lack intracellular membranes and in 
this particular study they were washed several times before 
measurement, these are likely to be minimum value Another 
reason why this area is worthy of careful examination is that 
the resting oxygen consumption of mammals is proportional 
to approximately the 0.75 power of body mass (75). This is 
the same allometric exponent observed for whole – mammal 
ethane exhalation rate, which is indicative of lipid peroxida-
tion (76) and for the degradation rates of T4 and T3 in mam-
mals (77). These findings of similar allometric exponents for 
these three processes means that, in mammals, irrespective 
of metabolic activity, there is a relatively constant molar ra-
tio between oxygen consumption, phospholipid peroxidation 
and deiodination of T4 and T3.
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SELENIUM AND THE THYROID GLAND
The thyroid contains more Se per gram of tissue than any 
other organ (78) and Se, like iodine, is essential for normal 
thyroid function and thyroid hormone homeostasis.
Selenium as an antioxidant in the thyroid 
During thyroid hormones synthesis, the thyrocyte is con-
tinually exposed to potentially toxic concentrations of H2O2 
and lipid hydroperoxides. The cytotoxic effects of H2O2 on 
thyroid cells include caspase-3-dependent apoptosis that oc-
curs at H2O2 concentrations that are insuffcient to induce 
necrosis. In Se deficiency the apoptotic response to H2O2 is 
increased (79). When Se intake is adequate the intracellular 
glutathione peroxidase (GPX) and thioredoxin reductases 
(TR) systems protect the thyrocyte from these peroxides. 
Furthermore, in iodine deficiency or Grave’s disease, where 
hyperstimulation of the TSH receptor signals increased H2O2 
production, activation of the calcium-phosphoinositol cas-
cade stimulates GPX1 production and particularly TR1 (80) 
thus providing an up-regulation of antioxidant protection. 
Thyroid hormone deiodinases and selenium
Three iodothyroinine deiodinases (D1, D2 and D3) have 
been identified. Each has a selenocysteine residue at the ac-
tive centre that confers the high catalytic activity of the en-
zymes. The deiodinases have differing substrate specificities 
and tissue distribution (81). The enzymes can catalyse the 
removal of iodine from the 5 or 5’ positions of iodothyronine 
substrates and in doing so have an important regulatory role 
in the activation and inactivation of the thyroid hormones 
in all tissues. Recently details of the protein structure of 
the deiodinases has become available. The extra-membrane 
portion of the deiodinases belongs to the thioredoxin-fold 
superfamily, a superfamily that also includes the GPXs. Fur-
thermore, a large deiodinase region embedded in the thiore-
doxin fold shares strong similarities with the active site of 
iduronidase, a member of the clan GH-A-fold glycoside hy-
drolases. The substrates for the deiodinases (iodothyronines 
such as thyroxine (T4), reverse tri-iodothyronine (rT3) and 
3,5,3’-tri-iodothyronine (T3) and substrates for the iduro-
nidase (sulphated -L-iduronic acid) are structurally simi-
lar, having O-linked hexagonal rings substituted with bulky 
groups lying ortho to the linker. It would thus appear that the 
deiodinases have iduronidase-like sequences embedded in 
the selenocyteine-containing thioredoxin fold that are critical 
for iodothyronine binding. The predicted protein structure of 
the deiodinases together with site-directed mutagenesis ex-
periments have allowed the elucidation of some of the critical 
amino acids that are responsible for the differences in sub-
strate specificity and enzyme kinetics observed between D1, 
D2 and D3 (82). The deiodinases show marked tissue- and 
time-specific expression during the foetal period and may be 
important regulators of this maturation process by modifying 
the supply of T3 to T3-responsive genes (83, 84). The deio-
dinase D1 is the major isoform in liver, kidney, thyroid and 
pituitary. It can catalyse 5 or 5’-monodeiodination and thus 
can convert T4 to the inactive metabolite rT3 or the active 
isomer T3. The important physiological roles of D1 include 
providing an important source of plasma T3 and degrading 
rT3 and T3 sulphate. 
 There are species-specific differences in the expression of 
D2. In rats, D2 is predominantly expressed in brain, brown 
adipose tissue and pituitary with little or no expression being 
found in thyroid, skeletal muscle or heart. In humans, North-
ern blotting or activity measurements suggest that D2 expres-
sion occurs in thyroid, heart, brain, spinal cord, skeletal mus-
cle, placenta, pituitary and keratinocytes and to some extent 
in kidney and pancreas. D2 can only perform 5’-deiodination 
reactions and the enzyme has a short half-life (<1 h), which is 
controlled by ubiquitination. Physiologically, D2 provides an 
intracellular source of T3 to specific tissues and, particularly 
in humans, it also appears to provide a significant source of 
plasma T3. Among its other physiological roles, D2 is critical 
for regulating brain development, TSH secretion in the pitui-
tary and adaptive thermogenesis in brown adipose tissue. D3 
is found in the plasma membrane of brain, placenta and foetal 
liver and performs only 5-monodeiodination (85).
In Se-suffcient rats, hepatic D1 provides an important 
source of circulating T3 yet in Se-deficient animals, when 
hepatic D1 expression falls to approximately 10% of that in 
Se-adequate animals, plasma T3 concentrations are largely 
maintained. The maintenance of plasma T3 in these Se-de-
ficient animals arises from an adaptive response driven by a 
rise in TSH that in turn signals increased de novo synthesis of 
T3 on thyroglobulin and also increased expression of thyroi-
dal D1 that promotes high rates of T4-to-T3 conversion (65, 
86). In humans, thyroidal D2 may also contibute to maintain-
ing plasma T3 in Se deficiency. The paradoxical increase in 
thyroidal D1 found in Se-deficient rats is made possible be-
cause the gland retains adequate amounts of the trace element 
in dietary Se deficiency (87). Not all animal species express 
thyroidal D1 and theoretically those lacking the enzyme may 
be less able to maintain plasma T3 concentrations in Se de-
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ficiency (88). Since D2 expression and T3 production are 
vital for regulating thermogenesis in brown adipose tissue, 
Se-deficient animals may show impaired production of D2 
and uncoupling protein, with poor survival when subjected 
to a cold stress (86). 
Selenium and iodine deficiency 
In humans, attention has focused on how Se status may mod-
ify the effects of iodine deficiency and the pathogenesis of 
endemic myxoedematous cretinism (89,86,90), a condition 
associated with severe hypothyroidism, thyroid involution 
and stunted growth. Some epidemiological studies have sug-
gested that the increased generation of H2O2 caused by the 
high TSH associated with iodine deficiency, together with a 
loss of thyroidal selenoperoxidase activity due to concurrent 
Se deficiency, produces the marked thyroid atrophy found 
in myxoedematous cretinism. In contrast, if Se supply is ad-
equate thyroid destruction may be prevented due to the main-
tenance of thyroidal GPX and TR. The importance of Se in 
protecting the thyroid from oxidative damage is supported by 
rodent experiments (91). These animal studies suggest also 
that myxoedematous cretinism may also result from a Se-
deficiency-induced disturbance in the inflammatory response 
(92). More recent reports have failed to provide convincing 
support for this hypothesis and the possible roles of other ad-
ditional factors such as dietary thiocyanates must again be 
considered (93).
Thyroid hormones, selenium and iodide excess
Environmental iodine deficiency continues to be a significant 
public health problem worldwide. On the other hand, iodide 
excess results principally from the use of iodine-containing 
medicinal preparations or radiographic contrast media. Io-
dide excess impairment on prooxidant/antioxidant balance of 
the thyroid gland, hepatic tissue and in blood and the effect 
of selenium administration on oxidative stress markers under 
the same circumstances were explored using an experimental 
model. Iodide excess had prooxidant effects, leading to an 
increased lipid peroxides level and catalase activity in target 
tissues and in blood and to a decreased H+ donor ability of 
the sera. Selenium supplementation had opposite effects (54).
Selenium and autoimmune thyroid disease 
The links between Se deficiency, altered immune function 
and inflammation have prompted studies in humans to exam-
ine if Se supplementation can modify auto-antibody produc-
tion in patients with chronic autoimmune thyroiditis. Dou-
ble-blind, randomized, placebo-controlled trials using daily 
Se supplements of 200 µg selenite produced a significant de-
cline in TPO antibody (TPOAb) concentration accompanied 
in some patients by an improved ultrasound echogenicity of 
the thyroid (94, 95). This effect of Se on TPOAb concen-
tration has been demonstrated both in an area of Germany 
with marginal dietary iodine and Se intakes (94) and in an 
area around Athens where iodine and Se intakes were close 
to requirement (96). In these studies Se supplements had no 
significant effect on the concentration of thyroglobulin anti-
bodies or the concentration of TSH or thyroid hormone con-
centrations. The mechanism by which Se exerts effects on 
TPOAb production is likely to be due to the ability of high 
doses of Se to modify the inflammatory and immune respons-
es (97). Further work is required to examine what long-term 
clinical benefits Se supplementation may have when given to 
patients with autoimmune thryoiditis. It would be important 
to determine if Se supplementation could modify the course 
of Graves’ disease since there is one report of Se supplements 
decreasing the concentration of TSH receptor antibodies in 
these patients (98). 
CONCLUSION
Thyroid hormones synthesis requires iodide, thyroglobulin 
and an oxidation system to oxidize iodide, to iodinate tyrosyl 
groups in thyroglobulin and couple them into iodothyronines. 
This oxidation system is constituted of a thyroperoxidase that 
oxidizes iodide in the presence of hydrogen peroxide and 
an ill-defined hydrogen peroxide generating system-using 
NADPH as coenzyme (10). Iodination mechanism consists 
in several steps, having iodinium (I+) and hypoiodite (IO-) 
as extremely reactive intermediate products. Thyroid hor-
mones pose a paradox: they both promote damage by ROS, 
by stimulating aerobic metabolic activity, but they also act as 
antioxidants themselves, as well as influencing other antioxi-
dant defence. The thyroid gland contains more selenium per 
gram of tissue than any other organ and selenium, like iodine, 
is essential for normal thyroid function and thyroid hormone 
homeostasis.
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